Résultats de recherche
ESC Clinical Practice Guidelines aim to present all the relevant evidence on a particular clinical issue in order to help physicians to weigh the benefits and risks of a particular diagnostic or therapeutic procedure. They should be helpful in everyday clinical medical decision-making.
- Acute Coronary Syndromes (Acs)
This guideline provides a comprehensive overview of the...
- Focused Update on Heart Failure
Since the publication of the 2021 ESC Guidelines for the...
- Cardiomyopathies
Cardiomyopathies - ESC Clinical Practice Guidelines -...
- CVD and Diabetes
The current Guidelines on cardiovascular disease and...
- Cardiac Pacing
Cardiac Pacing - ESC Clinical Practice Guidelines - European...
- Atrial Fibrillation
Atrial Fibrillation - ESC Clinical Practice Guidelines -...
- Acute Pulmonary Embolism
This document follows the previous ESC guidelines focusing...
- Acute Coronary Syndromes (Acs)
25 août 2023 · This guideline provides a comprehensive overview of the management of patients presenting with Acute coronary syndrome (ACS) from the point of diagnosis and risk stratification at initial presentation, through to long-term management after the initial hospitalisation period.
- Diabetes
- Cardio-Oncology
- Chronic and Acute Heart Failure
- Cardiovascular Disease Prevention
- Pulmonary Hypertension
Patients with diabetes are at higher risk of developing cardiovascular disease and having cardiovascular events, such as heart attacks, than patients without diabetes. This guide provides an overview of the latest evidence-based recommendations related to cardiovascular disease and diabetes. In particular, it should help you to understand: 1. The d...
Some cancer treatments may harm the heart and circulation. This document provides an overview of the latest recommendations on how these side effects can be prevented, diagnosed and treated. It should help patients to understand the importance of: 1. Being treated by a multidisciplinary cardio-oncology team, which means having a team of doctors, nu...
This guide for patients aims to provide an overview of the latest evidence-based recommendations for the diagnosis and treatment of heart failure. In particular, it should help patients to understand the: 1. main types of heart failure 2. medicines they may be offered 3. devices that might be considered appropriate 4. importance of being treated by...
This guide for patients aims to provide you with an overview of the latest evidence-based recommendations for the prevention of cardiovascular disease. In particular, it should help you to understand: 1. how cardiovascular disease risk is assessed 2. the importance of lifestyle modifications for prevention of cardiovascular disease 3. treatments an...
The European Lung Foundation (ELF) has developed a patient version of the joint European Society of Cardiology (ESC) and European Respiratory Society (ERS) clinical guidelines for pulmonary hypertension (PH). This document summarises the key points from the clinical guidelines and explains what PH is and recommendations to diagnose and treat it. Th...
25 août 2023 · The European Society of Cardiology (ESC) provides updated recommendations for the diagnosis and management of acute coronary syndromes (ACS) and myocardial infarction (MI). The guidelines cover triage, diagnosis, initial treatment, invasive strategy, reperfusion therapy, antithrombotic therapy, and secondary prevention.
Accédez aux recommandations de la Société Européenne de Cardiologie (ESC) en langue française sur votre smartphone. Cette application vous offre l'information médicale la plus récente et pertinente dans le domaine de la cardiologie.
27 août 2021 · The guidelines provide evidence-based recommendations for the diagnosis and treatment of heart failure with reduced, mildly reduced, or preserved ejection fraction. They cover natriuretic peptides, pharmacotherapy, cardiac rhythm management, devices, and multidisciplinary care.
26 août 2022 · A meta-analysis including 47 trials encompassing 3433 patients of all surgical disciplines showed that the use of washed cell salvage reduced the rate of exposure to allogeneic RBC transfusion by 39% ( P < 0.001), risk of infection by 28% ( P = 0.03), and length of stay by 2.31 days ( P < 0.001). 377.
